Involvement of moesin phosphorylation in ischemia/reperfusion induced inner blood-retinal barrier dysfunction

Jing Xu1, Qiong Liu1, Ming Ma1

  • 1Department of Ophthalmology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong Province, China.

Abstract

Insights

Retinal ischemia-reperfusion injury activates moesin phosphorylation via the p38 MAPK pathway, contributing to retinal vascular damage. Inhibiting this pathway protects the inner blood-retinal barrier.

Area of Science:

  • Ophthalmology
  • Vascular Biology
  • Cell Signaling

Background:

  • Retinal ischemia-reperfusion (RIR) insult causes significant retinal vascular damage.
  • Understanding the molecular mechanisms underlying RIR-induced vascular dysfunction is crucial for developing therapeutic strategies.

Purpose of the Study:

  • To investigate the role of moesin in retinal vascular damage following RIR.
  • To elucidate the signal transduction pathways, specifically the p38 MAPK pathway, involved in moesin activation during RIR.

Main Methods:

  • C57BL/6 mice underwent 45 minutes of retinal ischemia followed by reperfusion.
  • Moesin expression and phosphorylation were assessed using immunohistochemistry and Western blotting.
  • Inner blood-retinal barrier integrity was evaluated via FITC-dextran leakage assay.
  • The impact of p38 MAPK inhibition on moesin phosphorylation and vascular permeability was examined.

Main Results:

  • RIR induced a time-dependent increase in moesin phosphorylation post-reperfusion.
  • Inhibition of p38 MAPK significantly reduced moesin phosphorylation.
  • Blocking the p38 MAPK pathway also ameliorated inner blood-retinal barrier dysfunction.

Conclusions:

  • Moesin plays a critical role in RIR-induced retinal vascular endothelial dysfunction.
  • Phosphorylation of moesin is a key event triggered by p38 MAPK activation in response to RIR.
  • Targeting the p38 MAPK/moesin pathway may offer a therapeutic approach for RIR-related retinal vascular injury.

Related Concept Videos